Implications of viral resistance to amantadine in control of influenza A.

Keywords

Rimantadine, Amantadine, Medicine, Virology, Antiviral drug

References

• Occurrence of Adverse Effects and High Amantadine Concentrations With Influenza Prophylaxis in the Nursing HomeИван Николаевич Тюренков, Andrey Voronkov, Е. В. Петрова — 1990
• Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.Rebecca L. Tominack, Frederick G. Hayden — 1987
• Treatment of an Influenza A Outbreak in a Teaching Nursing HomeNancy L. Peters, Steven Oboler, Carole Hair — 1989
• Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infectionRobert B. Belshe, M. H. Smith, Charles B. Hall — 1988
• TOXIC EFFECTS OF AMANTADINE IN PATIENTS WITH RENAL FAILURETodd S. Ing, John T. Daugirdas, L S Soung — 1979
• Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).Eric E. Mast, Maurice W. Harmon, Stefan Gravenstein — 1991
• Children with influenza A infection: treatment with rimantadine.Caroline Breese Hall, Raphael Dolin, Christine L. Gala — 1987
• Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.John M. Quarles, Robert B. Couch, Thomas R. Cate — 1981
• Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.VICTOR W. HORADAM, JAMES G. SHARP, JERRY D. SMILACK — 1981
• A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in childrenJuliette Thompson, William F. Fleet, Eileen M. Lawrence — 1987
• PASSAGE OF INFLUENZA STRAINS IN THE PRESENCE OF AMINOADAMANTANEJ. S. Oxford, Ian Logan, C. W. Potter — 1970
• The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home.Nancy H. Arden — 1988
• STUDIES ON THE ANTIVIRAL ACTIVITY OF AMANTADINE HYDROCHLORIDE *Kenneth W. Cochran, H. F. Maassab, Akira Tsunoda — 1965
• Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramineV M Millet, M Dreisbach, Yvonne J. Bryson — 1982
• Multiple-dose pharmacokinetics of rimantadine in elderly adultsRebecca L. Tominack, Robert J. Wills, Linda E. Gustavson — 1988
• Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver diseaseRobert J. Wills, Robert B. Belshe, Diana Tomlinsin — 1987
• Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homesP. Patriarca, N A Kater, Alan P. Kendal — 1984
• In vivo Selection of an Influenza A2 Strain resistant to AmantadineJohn Oxford, Ian Logan, C. W. Potter — 1970
• Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)J. U. Postma, W. van Tilburg — 1975
• Summary of clinical trials of inactivated influenza vaccine - 1978.John R. La Montagne, Gary R. Noble, Gerald V. Quinnan — 1983

Cited by

• Morbidity and Mortality Weekly ReportWorld Kidney Day — 2012
• Control of Influenza in the Long-Term–Care Facility: A Review of Established Approaches and Newer OptionsEka Nur Muhammamah — 2000
• Rimantadine: A Clinical PerspectiveSusan M. Wintermeyer, Milap C. Nahata — 1995
• Management of InfluenzaHelen C. Jackson, Noel A. Roberts, Z. Michael Wang — 2000
• Comparison of Nosocomial Infections in Trauma and Surgical PatientsGina Pugliese, Martin S. Favero — 2000
• Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing HomeM. Schilling, Stefan Gravenstein, Paul J. Drinka — 2004
• Anti-influenza drugs and neuraminidase inhibitors.Noel A. Roberts — 2001
• The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.J. Ives, Jackie Carr, Dirk B. Mendel — 2002
• High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activityChing‐Yao Su, Ting-Jen Rachel Cheng, Meng‐I Lin — 2010
• Neuraminidase Inhibitors in the Treatment of Influenza A and B – Overview and Case ReportsPeter Wutzler, G Vogel — 2000
• Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.Arnold S. Monto, D. Paul Robinson, M. Louise Herlocher — 1999
• Amantadine and Rimantadine Prophylaxis of Influenza A in Nursing HomesDavid R.P. Guay — 1994
• Epidemiology of respiratory viruses in persons with and without asthma and COPD.Arnold S. Monto — 1995
• Animal models for the study of influenza pathogenesis and therapyDale L. Barnard — 2009
• Influenza virus resistance to neuraminidase inhibitors.Dirk B. Mendel, Robert W. Sidwell — 1998
• Expanding the treatment options for influenza.Richard P. Wenzel — 2000
• Antiviral therapy for influenza virus infections.Charles G. Prober — 2002
• The Clinical Efficacy of Influenza VaccinationArnold S. Monto — 2012
• The implications of drug resistance for strategies of combination antiviral chemotherapy.Douglas D. Richman — 1996
• Drug resistance in viruses.Douglas D. Richman — 1994

Related papers

• Successful treatment of naturally occurring influenza A/USSR/77 H1N1.L. P. Van Voris — 1981
• Long-term stability of the anti-influenza A compounds--amantadine and rimantadine.Christoph Scholtissek, Robert G. Webster — 1998
• Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.Janet A. Englund, R. Champlin, Philip R. Wyde — 1998
• Antivirals for the chemoprophylaxis and treatment of influenza.L. P. Van Voris, P M Newell — 1992
• Combination antiviral therapy for respiratory virus infections.Frederick G. Hayden — 1996
• An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A virusesYanmei Hu, Rami Musharrafieh, Chunlong Ma — 2017
• Emergence of amantadine-resistant influenza A viruses: epidemiological studyHiroshi Suzuki, Reiko Saito, Hiroki Masuda — 2003